p.97 抽出テキスト

692. Scheel PJ 3rd, Florido R, Hsu S, et al. Safety and utility of cardiopulmonary exercise testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Heart Assoc 2020; 9: e013695. PMID: 32009524 693. D’Ascenzi F, Solari M, Corrado D, et al. Diagnostic differentiation between arrhythmogenic cardiomyopathy and athlete’s heart by using imaging. JACC Cardiovasc Imaging 2018; 11: 1327- 1339. PMID: 30190032 694. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341: 1715-1724. PMID: 10580070 695. Daumy X, Amarouch MY, Lindenbaum P, et al. Targeted resequencing identifies TRPM 4 as a major gene predisposing to progressive familial heart block type I. Int J Cardiol 2016; 207: 349-358. PMID: 26820365 696. 蒔田直昌.進行性心臓伝導障害の基礎と臨床.心電図 2013;33 Suppl:34-42. 697. Shen WK, Sheldon RS, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2017; 14: e 155-e 217. PMID: 28286247 698. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. The Task Force for the diagnosis and management of syncope of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 1883- 1948. PMID: 29562304 699. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2631- 2671. PMID: 19713422 700. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of “high-risk” bundle-branch block: Final report of a prospective study. N Engl J Med 1982; 307: 137-143. PMID: 7088050 701. Denes P, Dhingra RC, Wu D, et al. Sudden death in patients with chronic bifascicular block. Arch Intern Med 1977; 137: 1005- 1010. PMID: 879938 702. Oseroff O, Galizio NO. Indication for pacing in patients with unexplained syncope and bifascicular block. In: Brignole M, Benditt DG, editors. Syncope: An evidence-based approach, 2nd edn. Springer, 2020: 255-259. 703. Santini M, Castro A, Giada F, et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: The PRESS study. Circ Arrhythm Electrophysiol 2 0 1 3 ; 6 : 1 0 1 - 1 0 7 . PMID: 23390123 704. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B 4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011; 32: 1535-1541. PMID: 21444367 705. Brignole M, Deharo JC, De Roy L, et al. Syncope due to idiopathic paroxysmal atrioventricular block: Long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011; 58: 167-173. PMID: 21570228 706. Blanc JJ, Le Dauphin C. Syncope associated with documented paroxysmal atrioventricular block reproduced by adenosine 5’ triphosphate injection. Europace 2014; 16: 923- 927. PMID: 24128810 707. Brignole M, Iori M, Solari D, et al. Efficacy of theophylline in patients with syncope without prodromes with normal heart and normal ECG. Int J Cardiol 2019; 289: 70-73. PMID: 30928258 708. Petkar S, Hamid T, Iddon P, et al. Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy--REVISE study. Europace 2012; 14: 1653- 1660. PMID: 22753867 709. Stein KM, Slotwiner DJ, Mittal S, et al. Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. Am Heart J 2001; 141: 282-288. PMID: 11174344 710. Sutton R, Fedorowski A, Olshansky B, et al. Tilt testing remains a valuable asset. Eur Heart J 2021; 42: 1654- 1660. PMID: 33624801 711. Abe H, Kohno R. Ictal asystole: relation to reflex syncope and role of cardiac pacing. In: Brignole M, Benditt DG, editors. Syncope: An evidence-based approach, 2nd edn. Springer, 2020: 299- 306. 712. Kohno R, Abe H, Akamatsu N, et al. Long-term follow-up of ictal asystole in temporal lobe epilepsy: Is permanent pacemaker therapy needed? J Cardiovasc Electrophysiol 2016; 27: 930- 936. PMID: 27172926 713. Kohno R, Abe H, Akamatsu N, et al. Syncope and ictal asystole caused by temporal lobe epilepsy. Circ J 2011; 75: 2508-2510. PMID: 21747190 714. Kohno R, Abe H, Hayashi K, et al. Pacemaker therapy for ictal asystole: potentially hazardous programming? Europace 2021; 23: 788. PMID: 33146736 715. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-676. PMID: 2326846 716. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41. PMID: 7678184 717. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2 0 1 3 ; 4 4 : 8 7 0 - 9 4 7 . PMID: 23370205 718. Hart RG, Diener HC, Coutts SB, et al. Cryptogenic Stroke/ ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014; 13: 429-438. PMID: 24646875 719. Bang OY, Ovbiagele B, Kim JS. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke 2014; 45: 1186-1194. PMID: 24578206 720. Providência R, Botelho A, Trigo J, et al. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace 2012; 14: 36-45. PMID: 21868410 721. Thambidorai SK, Murray RD, Parakh K, et al. ACUTE investigators. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005; 96: 935- 941. PMID: 16188520 722. Dussault C, Toeg H, Nathan M, et al. Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: Systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2 0 1 5 ; 8 : 2 6 3 - 2 6 9 . PMID: 25639643 723. Li YG, Bisson A, Bodin A, et al. C2 HEST score and prediction of incident atrial fibrillation in poststroke patients: A French Nationwide Study. J Am Heart Assoc 2019; 8: e012546. PMID: 31234697 724. Solomon SD, Zelenkofske S, McMurray JJ, et al. Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-2588. PMID: 15972864 725. Kim RJ, Albert TS, Wible JH, et al. Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayedenhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation 2008; 117: 629-637. PMID: 18212288 726. Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009; 54: 1770- 1777. PMID: 19874990 727. Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 2014; 130: 484- 495. PMID: 25092278 728. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013; 309: 896- 908. PMID: 23462786 729. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985. PMID: 17112987 730. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-133. PMID: 3336399 731. Aquaro GD, De Luca A, Cappelletto C, et al. Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2020; 75: 2753-2765. PMID: 32498802 732. Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts